
Prescription medication containing extended-release naltrexone, administered as an intramuscular injection once every four weeks. It is indicated for the following conditions:

Used to help patients with alcohol use disorder maintain abstinence and reduce the risk of relapse by decreasing alcohol cravings and the rewarding effects associated with drinking.

Used to prevent relapse to opioid use disorder following opioid detoxification by blocking the effects of opioids, such as heroin and prescription opioid pain medications.
Vivitrol is a prescription medication containing extended-release naltrexone. It is administered as an injection once every four weeks to help treat alcohol dependence and prevent relapse to opioid dependence after detoxification.
Vivitrol is indicated for:
Alcohol use disorder: To help patients maintain abstinence from alcohol.
Opioid use disorder: To help prevent relapse after opioid detoxification.
It is most effective when combined with counseling and other recovery support services.
Vivitrol blocks opioid receptors in the brain, reducing the effects of opioid medications and drugs. For alcohol use disorder, it can help reduce the rewarding effects of alcohol and support recovery.
The recommended dose is 380 mg, administered by a healthcare professional as a deep intramuscular injection into the buttock every four weeks, or once a month.
Vivitrol may be appropriate for adults with alcohol or opioid use disorders, depending on their medical history and treatment needs. A healthcare provider must assess the patient before treatment.
Yes. Patients should be able to abstain from alcohol before starting treatment and should not be actively drinking when they receive their first injection.
Yes. Vivitrol is intended to be part of a comprehensive treatment program that may include counseling, behavioral therapy, and recovery support.
Common side effects may include:
Side effects vary from person to person.
Yes. Important risks include severe injection-site reactions, liver problems, allergic reactions, and sudden opioid withdrawal if the patient has recently used opioids.
The patient should contact their healthcare provider as soon as possible to arrange the next injection. They should not attempt to compensate for a missed dose on their own.
No. Vivitrol is a treatment that can support recovery and help reduce the risk of relapse. Continued treatment, counseling, and follow-up are important.
Many Jewel-Osco can administer. We will search for an administration site near you.
Copyright © 2026 Mindful Harmony Clinic - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.